Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014467 |
| CAS No | NA |
| Mol.F. | C19H18FN5O4 |
| Mol.Wt. | 399.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014469 |
| CAS No | NA |
| Mol.F. | C28H35ClN6O4S |
| Mol.Wt. | 587.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014470 |
| CAS No | NA |
| Mol.F. | C28H34ClN7O5S |
| Mol.Wt. | 616.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014471 |
| CAS No | NA |
| Mol.F. | C28H34ClN7O5S |
| Mol.Wt. | 616.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014472 |
| CAS No | NA |
| Mol.F. | C27H27N3O8 |
| Mol.Wt. | 521.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014473 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O |
| Mol.Wt. | 348.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014474 |
| CAS No | 1053740-92-3 |
| Mol.F. | C22H30N4O6 |
| Mol.Wt. | 446.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014475 |
| CAS No | NA |
| Mol.F. | C28H35ClN6O4S |
| Mol.Wt. | 587.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014476 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O3 |
| Mol.Wt. | 291.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014477 |
| CAS No | NA |
| Mol.F. | C21H22Cl2N2O7 |
| Mol.Wt. | 485.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014478 |
| CAS No | NA |
| Mol.F. | C26H26N2O5 |
| Mol.Wt. | 446.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014479 |
| CAS No | NA |
| Mol.F. | C21H20F3IN4O3 |
| Mol.Wt. | 560.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014480 |
| CAS No | NA |
| Mol.F. | C21H20F3IN4O3 |
| Mol.Wt. | 560.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014481 |
| CAS No | NA |
| Mol.F. | C21H19F3IN5O4 |
| Mol.Wt. | 589.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014482 |
| CAS No | NA |
| Mol.F. | C21H21Cl2FN6O2 |
| Mol.Wt. | 479.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014483 |
| CAS No | NA |
| Mol.F. | C40H49N9O7 |
| Mol.Wt. | 767.9 |
| INV STATUS | CUSTOM SYNTHESIS |